number of participants with diabetes by trial cholesterol treatment trialists' (ctt)...
DESCRIPTION
Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25TRANSCRIPT
Number of participants with diabetes by trial
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Baseline characteristics of participants presenting with or without diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants
with and without diabetes by history of vascular disease
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline prognostic factors in participants with diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline lipid profi le in participants with diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25
Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol, by year, in participants with and without diabetes
Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25